Riskpilot← Back to searchSign inGet full accessMoradbakhti Medical AB
ABActiveOrg 5590170667Östra Kennelvägen 3Hospital activities · NACE 8610Est. 20150 employees
Revenue 2024
SEK 346K
EBITDA margin
88.3%
+4848% vs 2023
Equity ratio
15.1%
Financial strength
Net profit 2024
SEK 190K
+3133% vs 2023
| Revenue | SEK 346K | — |
| EBITDA | SEK 305K | +4848% |
| Net profit | SEK 190K | +3133% |
| Total assets | SEK 1,1M | +47% |
| Equity | SEK 166K | +120% |
| Employees | 0 | — |
Legal name
Moradbakhti Medical AB
Org number
5590170667
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
11 juni 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bedriva personaluthyrning, konsultation, behandling, undervisning, forskning och utveckling inom hälso- och sjukvård. Äga och förvalta fast och lös egendom.
Address
Östra Kennelvägen 3
Email
arash.moradbakhti@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 141 | 280 | 0 | 0 | 346 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 135 | 259 | −5 | −6 | 305 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 135 | 259 | −5 | −6 | 305 |
| Net financials | — | — | 1 | 12 | 13 |
| Profit before tax | 101 | 293 | −5 | 6 | 239 |
| Tax | −22 | −61 | — | — | −49 |
| Net profit | 79 | 232 | −5 | 6 | 190 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 585 | 825 | 744 | 750 | 1 100 |
| Equity | 192 | 424 | 70 | 75 | 166 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 359 | 401 | 674 | 674 | 855 |
| Total debt | 359 | 401 | 674 | 674 | 855 |
EBITDA margin
88.3%
This company
15.8%
Market median
+459% vs market
20202024
Equity ratio
15.1%
This company
38.2%
Market median
-60% vs market
20202024
Return on equity
114.8%
This company
18.4%
Market median
+524% vs market
20202024
Net profit margin
55.1%
This company
8.1%
Market median
+580% vs market
20202024
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20202024
Debt / equity
5.64×
This company
0.62×
Market median
-810% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Moradbakhti Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Arash Moradbakhti | Chief Executive Officer | 0 companies |
| Saeid Morad Bakhti | Deputy Board Member | 0 companies |